Celeste has 20 years of experience in biopharmaceutical and cell therapy operations, manufacturing, and supply chain. Before joining Neogene in 2021 as Head of Supply Chain, she built and led various areas of Kite Pharma’s cell therapy commercial supply chain, including Planning, Product lifecycle management, and US Regional Supply Chain contributing to the successful commercial launch and supply of YESCARTA™ and TECARTUS™. Prior to shifting to cell therapy, she held various roles at Amgen, including CMO management, manufacturing capacity planning, and establishment of the JAPAC supply chain. She started her career at Merck with monoclonal antibody manufacturing. Celeste earned her MBA from University of California Haas School of Business, M.Eng in Bioengineering from MIT, and B.S. in Chemical Engineering from MIT.
Menu
